Bailard, Inc. Horizon Therapeutics Public LTD CO Transaction History

Bailard, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$98.98 - $115.74 $159,555 - $186,572	-1,612 Reduced 3.28%	47,513 $5.5 Million
Q2 2023 Jul 20, 2023	SELL	$96.34 - $112.38 $5,587 - $6,518	-58 Reduced 0.12%	49,125 $5.05 Million
Q1 2023 May 08, 2023	SELL	$107.32 - $113.5 $6.27 Million - $6.63 Million	-58,395 Reduced 54.28%	49,183 $5.37 Million
Q4 2022 Feb 02, 2023	SELL	$62.39 - $113.8 $857,176 - $1.56 Million	-13,739 Reduced 11.32%	107,578 $12.2 Million
Q3 2022 Oct 18, 2022	SELL	$58.92 - $84.67 $2 Million - $2.87 Million	-33,884 Reduced 21.83%	121,317 $7.51 Million
Q2 2022 Jul 27, 2022	BUY	$79.4 - $116.36 $454,723 - $666,393	5,727 Added 3.83%	155,201 $12.4 Million
Q1 2022 Apr 25, 2022	SELL	$86.42 - $109.81 $6,567 - $8,345	-76 Reduced 0.05%	149,474 $15.7 Million
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $5,223 - $6,355	-53 Reduced 0.04%	149,550 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $285,472 - $342,809	3,106 Added 2.12%	149,603 $16.4 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $931,392 - $1.04 Million	10,800 Added 7.96%	146,497 $13.7 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $9.75 Million - $13 Million	135,697 New	135,697 $12.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.